Ironwood Pharmaceuticals, Inc. (IRWD) , a stock from Drugs – Generic Industry, has a value of $18.54 per share, noted a price change of 1.26% in recent trade close. The price to sales ratio is 8.46. The lower price P/S ratio indicates attractive the investment. A low P/S can also be effective in valuing growth stocks that have suffered a temporary setback. A low P/S ratio may indicate possible undervaluation, while a ratio that is significantly above the average may suggest overvaluation. Abbreviated as the P/S ratio or PSR, this ratio is also known as a “sales multiple” or “revenue multiple.”
Annual earnings per share (EPS) growth noted at -2.80% in past 5 Years and The company is estimating to achieve earnings per share (EPS) growth of -39.20% in this year and the earnings per share (EPS) growth expected to be 92.10% in the next year.
Analysts mean Recommendation on a stock is noted at 2.50. Analyst Recommendation is an outlook of a stock-market analyst on a stock. Rating Scale: 1.0 represent “Strong Buy” and 2.0 signify “Buy” 3.0 while shows “Hold”. 4.0 display “Sell” and 5.0 reveal “Strong Sell” rating.
The performance for week is 5.64% and the performance for quarter is at 27.95%. The performance for month is 5.10% and the performance for half year is 23.77%. Its monthly volatility value of 4.87% and volatility for the week is valued at 3.33%. The performance for Year to Date (YTD) is 23.68%.
The net percent change held by Institutional Investors has seen a change of 4.33% in last three month period. Insiders own 0.40% of Ironwood Pharmaceuticals, Inc. (IRWD) shares. During last six month record, the net percent change kept by insiders has observed a change of -25.48%.
Indicating how profitable this stock is relative to its assets, the ROA value is observed at -17.20%. The ROA tells us exactly what earnings were generated from the invested capital. A ROI of -19.40% for the company evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments.